Treace Medical Concepts (NASDAQ:TMCI) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

Treace Medical Concepts (NASDAQ:TMCI – Free Report) had its price target increased by Stifel Nicolaus from $7.00 to $8.00 in a research report sent to investors on Wednesday morning, Benzinga reports. Stifel Nicolaus currently has a hold rating on the stock. TMCI has been the topic of a number of other research reports. UBS Group […]

Leave a Reply

Your email address will not be published.

Previous post Stoke Therapeutics’ (STOK) Buy Rating Reaffirmed at Needham & Company LLC
Next post Rajeev K. Goel Sells 19,892 Shares of PubMatic, Inc. (NASDAQ:PUBM) Stock